Company profile: Culture Biosciences
1.1 - Company Overview
Company description
- Provider of cloud-connected bioreactors and Console software enabling remote, real-time design, monitoring, and analysis of cell culture and bioprocess experiments, plus bioprocess development services including clone screening, process characterization, media screening, and process optimization.
Products and services
- Cloud-Connected Bioreactors: Automated units for cell culture experiments that enable remote design, real-time monitoring, and analysis of bioprocesses and experiments through cloud connectivity
- ConsoleTM Software: Remote-access platform for real-time experiment design, run monitoring, and data analysis of bioprocess development from a remote location
- Bioprocess Development Services: Bioreactor-enabled programs delivering clone screening, media screening, process characterization, and process optimization experiments using their bioreactors for bioprocess development
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Culture Biosciences
QLT
HQ: Canada
Website
- Description: Provider of innovative ocular products, specializing in biotechnology and dedicated to their development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QLT company profile →
PreOmics
HQ: Germany
Website
- Description: Provider of innovative pre-analytics and sample preparation technologies for MS-based proteomics, supporting researchers in protein analysis. Offerings include iST kits for protein/peptide prep, TMT/iTRAQ-compatible chemical labeling (iST-NHS), minimized modifications in biofluids (iST-BCT), high-throughput positive-pressure prep (iST-PSI), peptide clean-up (iST Phoenix), and GFP IP enrichment (iST-Trap).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PreOmics company profile →
PrognomiQ
HQ: United States
Website
- Description: Provider of multi-omics liquid biopsy and proteomic profiling for early disease detection. Offers a platform integrating proteomics, genomics, and metabolomics for early-stage cancers such as lung and pancreatic, large-scale plasma proteomics for biomarker discovery, glycoproteome detection across cancer cohorts, and a multi-omics product pipeline for early detection and treatment of cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PrognomiQ company profile →
ArcticZymes Technologies
HQ: Norway
Website
- Description: Provider of enzymes and kits for medical research, developed and manufactured by a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ArcticZymes Technologies company profile →
Accellix
HQ: Israel
Website
- Description: Provider of a bench-top automated cell phenotyping platform for cell therapy quality control, integrating sample preparation, flow cytometry, and data analysis; pre-configured and custom assay kits for GMP workflows; algorithm-based autoanalysis for real-time cell subset classification; and QC assays to verify instrument performance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accellix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Culture Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Culture Biosciences
2.2 - Growth funds investing in similar companies to Culture Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Culture Biosciences
4.2 - Public trading comparable groups for Culture Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →